Articles Vol. 67 No. CĐ3-NCKH 02/04/2026

ASSOCIATED FACTORS OF TREATMENT COSTS OF INPATIENTS WITH TUBERCULOSIS AT BAC GIANG LUNG HOSPITAL IN 2024

Nguyen Thi Binh An1,2, Nguyen Luong Hung3,4
1 Thang Long University
2 Trường Đại học Thăng Long
3 Phuc Thuong Traditional Medicine Hospital
4 Bệnh viện Y học cổ truyền Phúc Thượng
DOI: 10.52163/yhc.v67iCD3.4739
23 Views
0 Downloads
Keywords
treatment cost, Tuberculosis, associated factors
Abstract

Objective: This study aims to describe the inpatient treatment costs and associated factors of inpatient cost of patients with Tuberculosis at the  Bac Giang Lung Hospital in 2024.

Subjects and Methods: A cross-sectional descriptive study using retrospective data from medical records and hospital invoices of inpatient in 2024. The total number of inpatients in this study was 405 patients. Descriptive analysis of mean, min, max and percentage was used to calculate the direct medical cost of TB patients. Linear regression was used to find associated factors of inpatients treatment costs

Results: The average total treatment cost per patient was VND 8.514.000. The associated factors included length stay, type of Tuberculosis and number of comorbidities. The average cost of inpatient care increases with longer hospital stays, a higher number of comorbid conditions, and multidrug-resistant cases.

Conclusion: The treatment cost of tuberculosis is considerably high, associated factors included length of stay, number of comorbid conditions, and type of Tuberculosis

References
[1]
World Health Organization (2023), Global Tuberculosis Report 2023. Google Scholar
[2]
Winston C. A. et al. (2023), "Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States", Emerging Infectious Diseases. 29 (10), pp. 2102-2104. Google Scholar
[3]
Hoàng Đình Tiếng et al. (2024), "Chi phí y tế trong điều trị bệnh Lao phổi nội trú có bảo hiểm y tế: nghiên cứu cắt ngang tại bệnh viện phổi vĩnh long năm 2023", Tạp Chí Y Học Việt Nam. 538 (2). Google Scholar
[4]
Nhung N. V. et al. (2018), "Measuring catastrophic costs due to tuberculosis in Viet Nam", Int J Tuberc Lung Dis. 22 (9), pp. 983-990. Google Scholar
[5]
Akalu T. Y. et al. (2023), "Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis", Scientific Reports. 13 (1), pp. 22361. Google Scholar
[6]
Li Q. et al. (2024), "Prevalence and epidemic pattern of ecdemic multidrug-resistant tuberculosis during 2012-2022 in Hangzhou, China: implication for public health strategies", BMC Public Health. 24 (1), pp. 2859. Google Scholar